IGFBP-2 plays critical roles in resistance to chemotherapy in many malignant tumors, such as breast cancer [14], esophageal adenocarcinoma [15], colon cancer [16], lung cancer [17], prostate cancer [18], glioma [19] and leukemia [20]. This evidence concerns the gene IGFBP2 and breast carcinoma.